Screening for obstructive sleep apnoea in an early psychosis cohort: a pilot study.


Journal

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
ISSN: 1440-1665
Titre abrégé: Australas Psychiatry
Pays: England
ID NLM: 9613603

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 10 10 2019
medline: 23 1 2021
entrez: 10 10 2019
Statut: ppublish

Résumé

Rates of obstructive sleep apnoea (OSA) appear to be lower in the youth population (< 4%) compared to the general population (6%-17%); rates in people with psychotic illness are estimated at 13.5%-57.1%. We hypothesised that this comorbidity extends to early psychosis (EP) populations, and used previously validated OSA questionnaires to screen for OSA in an EP cohort. Fifty-three patients were screened using the OSA50 and STOP-Bang questionnaires with collection of anthropometric measures. Patients who screened positively were referred for polysomnography. Fifteen per cent (8/53) screened positively; most frequently endorsed measures included BMI > 25, snoring, hypertension, neck circumference (> 40 cm) and male gender. Only 2/8 patients accepted polysomnography. Screening indicates OSA may be more prevalent in EP populations than age-equivalent cohorts, but ongoing research is required.

Identifiants

pubmed: 31595776
doi: 10.1177/1039856219878650
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-185

Auteurs

Abigail R Lane (AR)

Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.

Hannah Myles (H)

Northern Adelaide Local Health Network, Adelaide, SA.
Discipline of Psychiatry, Adelaide Medical School, Adelaide, SA, Australia.

Sharon Foley (S)

Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.

Dan Siskind (D)

Metro South Addiction and Mental Health Service, Brisbane, QLD.
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH